BioCentury
ARTICLE | Company News

Kosan cancer news

March 6, 2006 8:00 AM UTC

At Dec. 31, 2005, KOSN had $55.1 million in cash and a 12-month operating loss of $31 million. The company said it expects net cash use of $35-$40 million in 2006. KOSN has a $35 million credit facili...